Thor Medical ASA Logo

Thor Medical ASA

Producer and supplier of alpha-particle emitters for cancer therapy.

NANOV | OL

Overview

Corporate Details

ISIN(s):
NO0010597883 (+1 more)
LEI:
5967007LIEEXZXG6DK30
Country:
Norway
Address:
Drammensveien 167, 0277 Oslo

Description

Thor Medical ASA is a producer and supplier of alpha-particle emitters for cancer therapy. The company specializes in manufacturing isotopes, such as Thorium-228, by separating decay products from naturally occurring Thorium-232. This is achieved through a proprietary production technology that offers high efficiency, cost-competitiveness, and superior environmental friendliness. The company provides these critical alpha-emitters to partners developing next-generation targeted alpha therapies for precision oncology.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-04 08:00
RadioMedix and Thor Medical enter supply agreement for thorium-228 - Attachment…
English 53.4 KB
2025-12-04 08:00
RadioMedix and Thor Medical enter supply agreement for thorium-228
English 4.2 KB
2025-11-20 13:27
Thor Medical ASA - New share capital registered - Attachment: Download announce…
Norwegian 45.8 KB
2025-11-20 13:27
Thor Medical ASA - New share capital registered
English 1.9 KB
2025-11-20 07:30
Thor Medical enters supply agreement with NucliThera for thorium-228 - Attachme…
Norwegian 54.8 KB
2025-11-20 07:30
Thor Medical enters supply agreement with NucliThera for thorium-228
English 4.2 KB
2025-11-11 23:15
Thor Medical - Issuance of RSU shares to members of the board - Attachment: 202…
Norwegian 93.5 KB
2025-11-11 23:15
Thor Medical - Issuance of RSU shares to members of the board - Attachment: 202…
Norwegian 93.0 KB
2025-11-11 23:15
Thor Medical - Issuance of RSU shares to members of the board - Attachment: Dow…
Norwegian 50.5 KB
2025-11-11 23:15
Thor Medical - Issuance of RSU shares to members of the board
English 2.5 KB
2025-11-06 07:30
Thor Medical and Telix Pharmaceuticals sign strategic supply agreement for thor…
English 56.4 KB
2025-11-06 07:30
Thor Medical and Telix Pharmaceuticals sign strategic supply agreement for thor…
English 6.2 KB
2025-08-22 08:00
Invitation to presentation of Thor Medical ASA's 1H 2025 on Friday 29 August at…
English 50.3 KB
2025-08-22 08:00
Invitation to presentation of Thor Medical ASA's 1H 2025 on Friday 29 August at…
English 2.1 KB
2025-08-04 07:30
Thor Medical and AdvanCell expand strategic supply agreement for Thorium-228 - …
English 64.1 KB

Automate Your Workflow. Get a real-time feed of all Thor Medical ASA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Thor Medical ASA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Thor Medical ASA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.